Operations Portfolio

Our leadership team manages a portfolio of 16 companies, with an aggregate valuation exceeding $1.5BB and over $500MM in historical revenues. Our portfolio companies touch the entire life-cycle of pharma and life sciences sectors, including various sub-verticals such as drug discovery, medical devices, medical equipment, cancer therapeutics development, and pharmaceutical manufacturing. Our operational leadership team, with presence in the US, China and India, partner with founders and management teams of our portfolio companies to optimize efficiency, innovation and sustainable growth.